We are live on ! Find out more
PG

Pendal Group Portfolio holdings

AUM $11.6B
1-Year Est. Return 12.87%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
Cap. Flow
+$1.49B
Cap. Flow %
12.26%
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$463M
2
BABA icon
Alibaba
BABA
+$168M
3
UNH icon
UnitedHealth
UNH
+$142M
4
LIN icon
Linde
LIN
+$136M
5
CHKP icon
Check Point Software Technologies
CHKP
+$129M

Top Sells

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$115M
2
MEDP icon
Medpace
MEDP
+$115M
3
ORCL icon
Oracle
ORCL
+$112M
4
MKSI icon
MKS Inc
MKSI
+$99.1M
5
ARMK icon
Aramark
ARMK
+$92.8M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 16.66%
3 Financials 15.34%
4 Consumer Discretionary 9.67%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPEV icon
126
XPeng
XPEV
$12.5B
$7.58M 0.06%
213,412
+49,276
+30% +$1.96M
GS icon
127
Goldman Sachs
GS
$289B
$7.38M 0.06%
19,521
-406
-2% -$159K
NBIS
128
Nebius Group N.V.
NBIS
$37.6B
$7.34M 0.06%
+92,175
New +$6.72M
SQM icon
129
Sociedad Química y Minera de Chile
SQM
$19.3B
$7.25M 0.06%
+135,020
New +$6.89M
LYB icon
130
LyondellBasell Industries
LYB
$19.5B
$7.22M 0.06%
+76,932
New +$7.55M
MA icon
131
Mastercard
MA
$498B
$7.14M 0.06%
20,526
-12,245
-37% -$4.45M
OEC icon
132
Orion
OEC
$403M
$6.89M 0.06%
+378,150
New +$6.77M
SNPS icon
133
Synopsys
SNPS
$71.6B
$6.71M 0.06%
22,424
+15,494
+224% +$4.7M
WBD icon
134
Warner Bros
WBD
$64.3B
$6.5M 0.05%
+256,132
New +$7.2M
GSK icon
135
GSK
GSK
$107B
$6.47M 0.05%
+135,400
New +$6.8M
ADBE icon
136
Adobe
ADBE
$105B
$6.28M 0.05%
10,907
-3,344
-23% -$2.1M
BP icon
137
BP
BP
$112B
$6.24M 0.05%
+228,369
New +$5.72M
BN icon
138
Brookfield
BN
$102B
$6.2M 0.05%
214,776
-114,291
-35% -$3.34M
LTHM
139
DELISTED
Livent Corporation
LTHM
$6.09M 0.05%
+263,460
New +$5.91M
DE icon
140
Deere & Co
DE
$165B
$5.71M 0.05%
17,056
+15,366
+909% +$5.54M
INFY icon
141
Infosys
INFY
$51B
$5.66M 0.05%
254,232
+33,733
+15% +$762K
STX icon
142
Seagate
STX
$174B
$5.45M 0.05%
+66,016
New +$5.74M
JNJ icon
143
Johnson & Johnson
JNJ
$640B
$4.98M 0.04%
30,863
+5,428
+21% +$926K
ALL icon
144
Allstate
ALL
$70.6B
$4.97M 0.04%
39,035
-60,304
-61% -$7.97M
COF icon
145
Capital One
COF
$128B
$4.97M 0.04%
30,663
-21,928
-42% -$3.58M
ESS icon
146
Essex Property Trust
ESS
$19.1B
$4.81M 0.04%
15,032
+1,000
+7% +$324K
VTR icon
147
Ventas
VTR
$47.5B
$4.79M 0.04%
86,738
+4,314
+5% +$247K
TGT icon
148
Target
TGT
$66.3B
$4.75M 0.04%
20,756
-9,759
-32% -$2.44M
SCHW
149
Charles Schwab
SCHW
$182B
$4.74M 0.04%
65,046
-28,374
-30% -$2.03M
ECL icon
150
Ecolab
ECL
$79.8B
$4.72M 0.04%
22,619
-11,477
-34% -$2.52M
4 5
6
7 8

Similar funds

RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PCA
Personal Capital Advisors Redwood City, California $20.6B AUM 13.65% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Pendal Group's Q3 2021 Portfolio in Review

As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.

  • Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
  • Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
  • Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
  • Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
  • Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
  • Pendal Group opened 129 new positions and closed 109 in Q3 2021.
  • Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.

Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.